Singapore: A report by Cutting Edge Information titled, 'Post-patent generic and biosimilar defense: Harnessing competit...
Singapore: The Indian Health Ministry has banned the blockbuster diabetes drug Actos along with suspending sales of pain...
Singapore: The Chinese police have reportedly detained employees of British pharmaceuticals major GlaxoSmithKline (GSK) ...
Dr Yusuf K Hamied, CMD of India's largest pharma company, Cipla, has earned many unflattering epithets for building a co...
India's top drug regulatory body, the Central Drug Standard Control Organization (CDSO) is literally facing the heat, th...
Mumbai: Sun Pharmaceutical Industries received final approval from the US FDA for its abbreviated new drug application (...
Singapore: A new study by GlobalData has revealed that New Zealand's Pharmaceutical Management Agency's (PHARMAC) is emp...
Singapore: In support of its commitment to maximize growth opportunities in China, Eli Lilly has decided to increase its...
Singapore: A new report by investment bank Alpen Capital titled, 'The GCC pharmaceutical Outlook', a number of Gulf Coop...
Singapore: Japan's Meiji Seika Pharma is set to acquire Bangalore-based generic drug maker Medreich for $290 million. Th...
Two separate but equally important developments took place in China this month. One, intensification of investigations i...
Singapore: Mylan signed a new agreement between its subsidiary Mylan Laboratories and Gilead Sciences. According top thi...
Singapore: US-based Actavis reached a settlement agreement with AstraZeneca resolving outstanding patent litigation rela...
Singapore: Pharma industry leaders Pfizer and GlaxoSmithKline have joined hands with global engineering giants Siemens t...
Singapore: Generics are predicted to take over the antiviral drugs market, especially in the case of HIV medication, as ...
Hyderabad: Fujifilm and Dr Reddy's Laboratories have decided to terminate the memorandum of understanding (MoU) to enter...
Hyderabad: Dr Reddy's Laboratories (DRL) launched Zoledronic Acid Injection (4 mg/5 mL), a bioequivalent generic versio...
Singapore: Two weeks after intense investigations into GlaxoSmithKline's (GSK) operations across China, the country's se...
